111 (NASDAQ:YI) Director Jian David Sun Sells 111,100 Shares

111, Inc. Sponsored ADR (NASDAQ:YI) Director Jian David Sun sold 111,100 shares of 111 stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $0.23, for a total transaction of $25,553.00. Following the transaction, the director directly owned 472,011 shares in the company, valued at approximately $108,562.53. The trade was a 19.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jian David Sun also recently made the following trade(s):

• On Wednesday, June 10th, Jian David Sun sold 115,440 shares of 111 stock. The shares were sold at an average price of $0.22, for a total transaction of $25,396.80.
• On Tuesday, June 9th, Jian David Sun sold 12,000 shares of 111 stock. The shares were sold at an average price of $0.23, for a total transaction of $2,760.00.
• On Wednesday, May 27th, Jian David Sun sold 70,440 shares of 111 stock. The shares were sold at an average price of $0.25, for a total transaction of $17,610.00.
• On Tuesday, May 26th, Jian David Sun sold 29,280 shares of 111 stock. The shares were sold at an average price of $0.27, for a total transaction of $7,905.60.

111 Stock Down 1.8%

Shares of YI stock opened at $4.28 on Friday. The firm has a market cap of $37.62 million, a price-to-earnings ratio of -3.06 and a beta of 0.60. The company’s 50 day moving average is $5.95 and its 200 day moving average is $5.64. 111, Inc. Sponsored ADR has a 52-week low of $2.48 and a 52-week high of $11.17.

Analysts Set New Price Targets

Separately, Weiss Ratings downgraded shares of 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, June 4th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock presently has an average rating of “Sell”.

111 Company Profile

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.